Take 26% Gains on Indian Pharma Giant Dr. Reddy’s (RDY)
Sep 25th, 2009 | By J. Christoph Amberger | Category: Stock Market InvestingIt’s a rainy day and the markets are all but inspiring. So take gains on Dr. Reddy’s Laboratories Limited (NYSE:RDY) and buy yourself a cuppa cheer!
Don’t tell me we’re not doing anything for readers of of free service, the TFN eNews, and visitors of our TFN home page.
On August 20, we posted a free TFN Special Report, The Top Swine Flu Vaccine Stocks under $20, in which we recommended three stocks.
One of them, Sinovac (AMEX:SVA), gave us 30% gains on Aug. 28.
Today, the arguably largest and slowest-moving of the pig flu trip stepped on the gas. On Aug. 20, I recommended you “buy Dr. Reddy’s Laboratories Limited (NYSE:RDY) under $16.50 for possible gains of 10-15% throughout 2010.”
Today, our Indian generics wallah is trading at $20.43. In our TFN tracking portfolio, this clocks in as a 25.95% gain.
I say we take it!
Source: Take 26% Gains on Indian Pharma Giant Dr. Reddy’s (RDY)
Advertisement
42% on Nymox Pharmaceutical Corp....
23% on Emergent BioSolutions Inc....
38% on the first half of our position in a U.S. refiner...
26.68% on Synta Pharmaceuticals...
How's your favorite financial newsletter working out for you?
Hot Stock Confidential = Damn Good Stocks.
Learn more...
Amberger began his career as a freelance contributor to Agora publications before emigrating from Germany to the United States in 1989, when he joined the editorial board of Taipan. In 1991, he took over as managing editor for the publication and assumed responsibility as group publisher four years later. In 2007 Christoph left Taipan and founded TodaysFinancialNews.com along with its premium publications: the highly successful stock Hot Stock Confidential, the options research service TFN Strategic Trader and, most recently, Penny Stock Confidential. In November of 2009, he welcomed Contrarian Profits to the Today's Financial News network.
